Loading...
Docoh

Liquidia (LQDA)

Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC.

Company profile

Ticker
LQDA
Exchange
CEO
Neal F. Fowler
Employees
Incorporated
Location
Fiscal year end
SEC CIK

LQDA stock data

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

6 Nov 20
1 Jul 22
31 Dec 22
Quarter (USD) Sep 20 Jun 20 Mar 20 Sep 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
43.4% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 72 52 +38.5%
Opened positions 25 14 +78.6%
Closed positions 5 8 -37.5%
Increased positions 26 19 +36.8%
Reduced positions 10 9 +11.1%
13F shares Current Prev Q Change
Total value 148.27M 175.26M -15.4%
Total shares 27.91M 24.48M +14.0%
Total puts 0 25.3K EXIT
Total calls 103.6K 30.6K +238.6%
Total put/call ratio 0.8
Largest owners Shares Value Change
Caligan Partners 7.17M $28.96M 0.0%
Canaan VIII 2.92M $8.61M 0.0%
Eshelman Ventures 1.88M $5.51M 0.0%
Vanguard 1.66M $11.91M +2.9%
Millennium Management 1.54M $11.06M +52.1%
Xeraya LT 1.4M $4.12M 0.0%
Eversept Partners 1.38M $9.89M -4.9%
Kynam Capital Management 1.16M $8.33M -15.2%
BLK Blackrock 846.39K $6.08M +0.4%
Citadel Advisors 783.4K $5.63M +1262.7%
Largest transactions Shares Bought/sold Change
Citadel Advisors 783.4K +725.91K +1262.7%
Millennium Management 1.54M +527.46K +52.1%
Soviero Asset Management 420K +420K NEW
Point72 Asset Management 282.18K +282.18K NEW
IVZ Invesco 257.72K +257.72K NEW
Kynam Capital Management 1.16M -207.16K -15.2%
Pura Vida Investments 251.6K +200.2K +389.5%
EAM Investors 195.81K +195.81K NEW
Renaissance Technologies 0 -167.32K EXIT
Opaleye Management 178.8K +162K +964.3%

Financial report summary

?

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: ACCP, al, animal, attended, Canada, cashflow, CDER, College, complementary, counterparty, Eastern, France, French, Germany, ISHLT, motion, NaN, online, pharmacokinetic, prematurely, Presidential, proceed, PVRI, quarantine, reposition, rescheduled, rulemaking, sought, survival, tentative, Transplantation, tying, unanimously, unnecessarily, unpatentable, unsolicited, Vascular, virtual, webcast
Removed: attributed, Azar, borrowed, comparing, crossover, distance, encumbered, exceeded, half, incurring, Minnesota, observe, practical, prohibiting, Questionnaire, repaid, supplement, supportive, systemic, tolerated, variation, walk